In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cytokinetics Inc.

www.cytokinetics.com

Latest From Cytokinetics Inc.

Heralding Change: Product Pipeline Advances To Watch Out For In Q3

Key events that could move innovative product candidates nearer the market in the third quarter of 2019 are highlighted in a new Biomedtracker/Meddevicetracker report.

Approvals Clinical Trials

Gottlieb's Pfizer Board Seat: Quick, Bold, But Not Unusual For An Ex-Commish

While nearly all former FDA commissioners have served on the board of a pharmaceutical company, a Pink Sheet analysis finds that many have also served on the board of non-profit institutions after leaving public service.  

FDA Leadership

Q&A: SVP Elliott Levy On Amgen R&D's 'Singular Focus On Innovation'

Scrip spoke with Levy, senior vice president of global development, about the company's novel candidates for cardiovascular and inflammatory diseases and cancer, including modalities outside of its primary focus on biologics and small molecules.

Research and Development Strategies Cardiovascular

Cytokinetics Sees Enough Evidence To Move Reldesemtiv Into Phase III For ALS

The Astellas-partnered drug did not reach statistical significance on any FORTITUDE-ALS endpoints, but clinically significant results over time justify a longer Phase III study that's likely to enroll ALS patients with a faster rate of disease progression.

Clinical Trials Neurology
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cytokinetics Inc.
  • Senior Management
  • Robert I Blum, Pres. & CEO
    Sharon Barbari, EVP, Fin. & CFO
    Andrew A Wolff, MD, SVP, CMO
    Elisabeth A Schnieders, PhD, SVP, Bus. Dev.
    Scott R Jordan, VP, Commercial Dev.
  • Contact Info
  • Cytokinetics Inc.
    Phone: (650) 624-3000
    280 East Grand Ave.
    S. San Francisco, CA 94080
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register